---
title: "Leqvio (inclisiran), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Leqvio (inclisiran) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing, Administration, and Prescribing. Questions: What is the recommended dosage of Leqvio? How many Leqvio injections are needed per year? What should be done if a Leqvio dose is missed? Can patients self-inject Leqvio at home? 4 further questions follow. 8 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/leqvio/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Leqvio (inclisiran), all indications: Dosing and administration questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Leqvio](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf)  
Indication pages: [Hypercholesterolemia](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia)

## Dosing

<a id="leqvio-dosage"></a>

### What is the recommended dosage of Leqvio?

> “The recommended dosage of LEQVIO for adults and pediatric patients aged 12 years and older is 284 
> mg administered as a single subcutaneous injection initially, again at 3 months, and then every 6 
> months.”

Source: [LEQVIO: Prescribing information, page 2, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=2)

<a id="leqvio-doses-per-year"></a>

### How many Leqvio injections are needed per year?

> “2 initial doses, then 2 doses a year<sup>1</sup>”

Source: [LEQVIO: Dosing & Administration | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/dosing-and-administration#:~:text=2%20initial%20doses%2C%20then%202%20doses%20a)

<a id="leqvio-missed-dose"></a>

### What should be done if a Leqvio dose is missed?

> “If a planned dose is missed by less than 3 months, administer LEQVIO and maintain dosing according to 
> the patient’s original schedule. 
> • If a planned dose is missed by more than 3 months, restart with a new dosing schedule - administer 
> LEQVIO initially, again at 3 months, and then every 6 months.”

Source: [LEQVIO: Prescribing information, page 2, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=2)

## Administration

<a id="leqvio-self-injection"></a>

### Can patients self-inject Leqvio at home?

> “LEQVIO should be administered by a healthcare professional.”

Source: [LEQVIO: Prescribing information, page 2, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=2)

> “LEQVIO is a subcutaneous injection that can be given by any state-certified HCP<sup>1</sup>”

Source: [LEQVIO: Dosing & Administration | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/dosing-and-administration#:~:text=LEQVIO%20is%20a%20subcutaneous%20injection%20that%20can%20be%20given%20by%20any%20state%2Dcertified)

<a id="leqvio-injection-sites"></a>

### Where is Leqvio injected?

> “Inject LEQVIO subcutaneously into the abdomen, upper arm, or thigh. Do not inject in areas of active 
> skin disease or injury, such as sunburns, skin rashes, inflammation, or skin infections.”

Source: [LEQVIO: Prescribing information, page 2, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=2)

<a id="leqvio-injection-steps"></a>

### How is the Leqvio prefilled syringe injected?

> “Step 3. Remove needle cap 
> Firmly pull straight to remove the needle cap from the prefilled 
> syringe (see Figure B). You may see a drop of liquid at the end 
> of the needle. This is normal. 
> Do not put the needle cap back on. Throw it away. 
> Note: Do not remove the needle cap until you are ready to inject. 
> Early removal of the needle cap prior to injection can lead to 
> drying of the drug product within the needle, which can result in 
> needle clogging. 
>
> Step 4. Insert the needle 
> Gently pinch the skin at the injection site and hold the pinch 
> throughout the injection. With the other hand insert the needle 
> into the skin at an angle of approximately 45 degrees as shown 
> (see Figure C). 
>
>
> Step 5. Inject 
> Continue to pinch the skin. Slowly press the plunger as far as it 
> will go (see Figure D). This will make sure that a full dose is 
> injected. 
> Note: If you cannot depress the plunger following insertion of the 
> needle, use a new prefilled syringe.  
>
>
>
>
> Step 6. Complete injection and dispose of the prefilled syringe 
> Remove the prefilled syringe from the injection site. Do not put the needle cap back on.  
> Dispose of the prefilled syringe in an FDA-cleared sharps disposal container right away after use.”

Source: [LEQVIO: Prescribing information, page 19, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=19)

Note: The steps are from the Instructions for Use printed with the Prescribing Information, which is intended for healthcare professionals.

<a id="leqvio-fasting"></a>

### Does Leqvio require fasting before the injection?

> “No fasting requirements”

Source: [LEQVIO: Dosing & Administration | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/dosing-and-administration#:~:text=No%20fasting%20requirements)

## Prescribing

<a id="leqvio-specialty-pharmacy-prescription"></a>

### How should a specialty pharmacy prescription for Leqvio be written?

> “Considerations for Writing Specialty Pharmacy Prescriptions for LEQVIO®
> When you are acquiring LEQVIO through a specialty pharmacy, it is important to ensure that the prescription  
> is written completely and accurately. Your prescription may be rejected if it is incorrectly written. 
> Please see below for some considerations on how you may write the two prescriptions for LEQVIO.”

Source: [LEQVIO: LEQVIO Prescription Considerations, page 1, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612154_LEQ_Prescription_Considerations_Resource_-_Digital-Label_Update_-_2-26/FA-11612154.PDF#page=1)

> “Dose Type
> 284 mg/1.5 mL (189 mg/mL) in a single-dose prefilled syringe
> Quantity
> 1
> Refill
> 1
> Administration
> •	HCP to inject inclisiran subcutaneously into the abdomen, 
> upper arm, or thigh
> •	HCP to administer initially and again at 3 months
> Dose Type
> 284 mg/1.5 mL (189 mg/mL) in a single-dose prefilled syringe
> Quantity
> 1
> Refill
> 1
> Administration
> •	HCP to inject inclisiran subcutaneously into the abdomen, 
> upper arm, or thigh
> •	HCP to administer every 6 months after the first two doses”

Source: [LEQVIO: LEQVIO Prescription Considerations, page 1, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612154_LEQ_Prescription_Considerations_Resource_-_Digital-Label_Update_-_2-26/FA-11612154.PDF#page=1)

> “Prescription #1: Initial Doses (Day 0 and Day 90)
> Prescription #2: Maintenance Doses (Every 6 Months After the 
> First 2 Doses)”

Source: [LEQVIO: LEQVIO Prescription Considerations, page 1, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612154_LEQ_Prescription_Considerations_Resource_-_Digital-Label_Update_-_2-26/FA-11612154.PDF#page=1)

Note: In the document, the first block of dose type, quantity, refill, and administration is Prescription #1 (initial doses) and the second is Prescription #2 (maintenance doses).

## Related pages
- [Medical information: Leqvio (inclisiran): All indications](https://www.evicenter.com/medical-information/leqvio)
- [Indication](https://www.evicenter.com/medical-information/leqvio/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/leqvio/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/leqvio/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/leqvio/safety)
- [Specific populations](https://www.evicenter.com/medical-information/leqvio/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/leqvio/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/leqvio/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/leqvio/access-and-coverage)
